Real Estate Agencies Seeking Loan in Lewes

A fintech startup with high growth potential. - Our project manager has over 10 years of experience in leading tech and eCommerce projects, and has successfully managed multiple large-scale digital initiatives. - Our marketer has a proven track record in digital marketing and user acquisition, having previously launched two successful mini apps, with one of them having 500,000 users and the another one with 150,000 users. - Our development team is composed of seasoned professionals with a combined experience of over 15 years in software development, specializing in both front-end and back-end technologies. - We seek investments to develop new mini game app based on crypto with projected profits of $1,200,000 per year in the next 9-12 months. - Our operations are 100% online. - Projected net margins at 80%+ (EBITDA). - Our new product will have a prototype in 2 months and will be launched in 3 months.

Independent auditor's report: Consolidated financial statements (last 3 years): The consolidated financial statements of our company and its subsidiaries (the group) for last 3 fiscal years have been audited in accordance with International Standards on Auditing (ISAs). Our examination confirms the fair presentation of the group's financial position, with revenue recognition complexities across Venezuela, Colombia, and the United States emerging as critical audit areas. The group demonstrated a 45.8% gross margin improvement by last year despite geopolitical challenges in its core Latin American markets. Key findings include robust trademark valuation growth (reaching $3,105,988 last year) and successful implementation of a multi-channel distribution strategy that increased cross-selling efficiency by 67.1% - Report on the audit of consolidated financial statements: Our opinion: We have audited the consolidated financial statements of our company and its subsidiaries, comprising: - Consolidated statements of financial position as of December 31 since last 3 years. - Consolidated statements of comprehensive income. - Consolidated cash flow statements. - Notes detailing significant accounting policies under IFRS. In our opinion, these financial statements present fairly, in all material respects: - The group's financial position across its Delaware headquarters, Venezuelan subsidiary, and Colombian operation. - Operational results reflecting its strategic shift from distributor-dependent sales to direct channel management. - Cash flows impacted by working capital fluctuations, including a 52.79% cash reduction offset by improved inventory turnover. Basis for opinion: Our audit adhered to ISAs and IESBA code requirements, incorporating: - Entity-specific risk assessment: Evaluated geopolitical exposures in Venezuela (OFAC compliance) and currency risks in Colombia. - Revenue testing: Sampled 39% of transactions across 64.18% traditional, 23.39% retail, and 8.06% e-commerce channels. - Valuation analysis: Engaged specialists to validate level 3 financial instruments tied to the $5 million debt issuance program. Key audit matters: Multi-jurisdictional revenue recognition (IFRS 15) The group's revenue streams require complex assessment due to: - Geographical diversity: 43.8% brand coverage across three regulatory regimes. - Contract variability: Franchise entrance fees (4.37% of sales) vs. government tender payments. - Cut-off procedures: Verified timing of $6.28 million in last year's sales through shipment documentation and bank confirmations. Audit response: - Tested 78 contracts representing 61% of total revenue. - Reconciled Amazon best-seller rankings (Mi Ni Care brand) with e-commerce receipts. - Confirmed HORECA channel sales through third-party attestations. Intangible asset valuation (IAS 38): Trademark portfolio growth ($2.34M to $3.11M over the last 3 years) required evaluation of: - Brand royalty rates: Compared to industry benchmarks (7-12% royalty range) - Market penetration: Analyzed 76.3% SKU coverage improvement. - Legal protections: Verified patent filings for products formulations. Audit response: - Performed impairment indicators analysis using same-store sales metrics. - Tested trademark renewal payments against USPTO records. - Assessed dilution risks from counterfeit products in Venezuelan market. - Debt instrument fair value (IFRS 13) The $5 million debt issuance necessitated: - Credit spread analysis: Compared to BB-rated Latin American consumer goods issuers. - Hedging effectiveness: Evaluated cross-currency swaps for USD/VES exposures. - Covenant compliance testing: Debt/EBITDA ratio maintenance at 3.2x. Audit response: - Modeled 5-year cash flows under 3 macroeconomic scenarios. - Validated debt pricing against Bloomberg terminal data. - Confirmed hedge accounting treatment with derivative specialists. Other Information: Management’s annual report discusses: - Post-pandemic recovery strategies yielding 17.3% sales growth (over the last 3 years) - Supply chain optimization reducing COGS by 14.6% since 3 years. - Environmental engineering initiatives: No material inconsistencies were identified between management commentary and audited financials. Governance and responsibilities: Management’s role: The executive team (CEO and COO) implemented: - Franchise expansion model: Increased activation rates by 53.7% through FED framework. - Product diversification: Launched oncology-specific line while maintaining 37.9–45.8% gross margins. - Risk mitigation: Maintained OFAC-compliant operations despite Venezuelan sanctions. Auditor’s responsibilities: Our procedures addressed: - Going concern: Analyzed liquidity buffers against $1.43M current assets (2 years ago) - Related parties: Confirmed arm’s length terms with founders' family-owned distribution networks. - Tax compliance: Reviewed transfer pricing documentation for intercompany transactions. Conclusion: Our company’s consolidated financial statements for the last 3 years represent fairly its financial recovery and strategic repositioning. The audit opinion remains unmodified despite challenges posed by: - Working capital volatility: inventory surge to $460,569.77 2 years ago. - Currency risks: VES devaluation impacts on Colombian subsidiary results. - Ownership concentration: 57.5% control by founder. The group demonstrates capacity to execute its $7–10 million valuation growth plan, supported by improved operational metrics and defensible IP portfolio.

Independent auditor's report: Consolidated financial statements (last 3 years): The consolidated financial statements of our company and its subsidiaries (the group) for last 3 fiscal years have been audited in accordance with International Standards on Auditing (ISAs). Our examination confirms the fair presentation of the group's financial position, with revenue recognition complexities across Venezuela, Colombia, and the United States emerging as critical audit areas. The group demonstrated a 45.8% gross margin improvement by last year despite geopolitical challenges in its core Latin American markets. Key findings include robust trademark valuation growth (reaching $3,105,988 last year) and successful implementation of a multi-channel distribution strategy that increased cross-selling efficiency by 67.1% - Report on the audit of consolidated financial statements: Our opinion: We have audited the consolidated financial statements of our company and its subsidiaries, comprising: - Consolidated statements of financial position as of December 31 since last 3 years. - Consolidated statements of comprehensive income. - Consolidated cash flow statements. - Notes detailing significant accounting policies under IFRS. In our opinion, these financial statements present fairly, in all material respects: - The group's financial position across its Delaware headquarters, Venezuelan subsidiary, and Colombian operation. - Operational results reflecting its strategic shift from distributor-dependent sales to direct channel management. - Cash flows impacted by working capital fluctuations, including a 52.79% cash reduction offset by improved inventory turnover. Basis for opinion: Our audit adhered to ISAs and IESBA code requirements, incorporating: - Entity-specific risk assessment: Evaluated geopolitical exposures in Venezuela (OFAC compliance) and currency risks in Colombia. - Revenue testing: Sampled 39% of transactions across 64.18% traditional, 23.39% retail, and 8.06% e-commerce channels. - Valuation analysis: Engaged specialists to validate level 3 financial instruments tied to the $5 million debt issuance program. Key audit matters: Multi-jurisdictional revenue recognition (IFRS 15) The group's revenue streams require complex assessment due to: - Geographical diversity: 43.8% brand coverage across three regulatory regimes. - Contract variability: Franchise entrance fees (4.37% of sales) vs. government tender payments. - Cut-off procedures: Verified timing of $6.28 million in last year's sales through shipment documentation and bank confirmations. Audit response: - Tested 78 contracts representing 61% of total revenue. - Reconciled Amazon best-seller rankings (Mi Ni Care brand) with e-commerce receipts. - Confirmed HORECA channel sales through third-party attestations. Intangible asset valuation (IAS 38): Trademark portfolio growth ($2.34M to $3.11M over the last 3 years) required evaluation of: - Brand royalty rates: Compared to industry benchmarks (7-12% royalty range) - Market penetration: Analyzed 76.3% SKU coverage improvement. - Legal protections: Verified patent filings for products formulations. Audit response: - Performed impairment indicators analysis using same-store sales metrics. - Tested trademark renewal payments against USPTO records. - Assessed dilution risks from counterfeit products in Venezuelan market. - Debt instrument fair value (IFRS 13) The $5 million debt issuance necessitated: - Credit spread analysis: Compared to BB-rated Latin American consumer goods issuers. - Hedging effectiveness: Evaluated cross-currency swaps for USD/VES exposures. - Covenant compliance testing: Debt/EBITDA ratio maintenance at 3.2x. Audit response: - Modeled 5-year cash flows under 3 macroeconomic scenarios. - Validated debt pricing against Bloomberg terminal data. - Confirmed hedge accounting treatment with derivative specialists. Other Information: Management’s annual report discusses: - Post-pandemic recovery strategies yielding 17.3% sales growth (over the last 3 years) - Supply chain optimization reducing COGS by 14.6% since 3 years. - Environmental engineering initiatives: No material inconsistencies were identified between management commentary and audited financials. Governance and responsibilities: Management’s role: The executive team (CEO and COO) implemented: - Franchise expansion model: Increased activation rates by 53.7% through FED framework. - Product diversification: Launched oncology-specific line while maintaining 37.9–45.8% gross margins. - Risk mitigation: Maintained OFAC-compliant operations despite Venezuelan sanctions. Auditor’s responsibilities: Our procedures addressed: - Going concern: Analyzed liquidity buffers against $1.43M current assets (2 years ago) - Related parties: Confirmed arm’s length terms with founders' family-owned distribution networks. - Tax compliance: Reviewed transfer pricing documentation for intercompany transactions. Conclusion: Our company’s consolidated financial statements for the last 3 years represent fairly its financial recovery and strategic repositioning. The audit opinion remains unmodified despite challenges posed by: - Working capital volatility: inventory surge to $460,569.77 2 years ago. - Currency risks: VES devaluation impacts on Colombian subsidiary results. - Ownership concentration: 57.5% control by founder. The group demonstrates capacity to execute its $7–10 million valuation growth plan, supported by improved operational metrics and defensible IP portfolio.

Web & mobile development and branding & design firm registered in Delaware. - The owner is currently running the business from North Macedonia and is working worldwide. - Have 2 clients (one-time contract) and have completed 12 one-time projects in the first 6 months of operations. - Recently added another client with whom we have signed a long-term contract. - Most of the clients are from the food and beverage industry. - We have been placed in the top 10 branding companies, according to DesignRush. - Promoter has 8 years of experience as a UI & UX designer. - We seek investment and investor/partner to open an office in North Macedonia and upgrade our marketing with an online live show in North Macedonia and the USA.

Business Highlights: - Founded 4 years ago, began with a COVID-19 experiment using 1,300 samples, achieving an impressive 99.77% accuracy compared to RT-PCR. - Intellectual property: Secured a patent grant, solidifying our innovative approach in AI-driven diagnostics. - Accelerator & industry recognition: Selected for The Roux Institute’s Future of Healthcare acceleration program, providing mentorship and strategic growth opportunities. - Non-dilutive & early investment traction: Gained momentum with multiple grants and secured a $50K pre-seed investment, fueling research and development. - E. coli study success: Conducted a preclinical study demonstrating 87% accuracy, further validating our RF-based pathogen detection technology. - Funding & resources: Currently leveraging USD 725K in total grants and credits, including K in USD 70 K grants received, USD 350K in Google Cloud credits, and an expected USD 305K SBIR grant from NSF. - Industry partnerships & market strategy: -- NorDx is set to be our first commercial client upon market entry. - Recognition & awards: -- Accepted into the Nvidia Inception Program for AI innovation. -- Runner-up in the AWS x Nvidia pitch competition in Austin, positioning business at the forefront of AI-powered diagnostics. - Market Launch & Revenue. - Fundraising progress: Raising USD 3M to commercialize, with USD 105K secured through SAFE notes and strong investor interest. - Business Model & Revenue Potential: Projected first-year revenue of USD 3M, with sales of 600 diagnostic units upon launch. Scalable B2B model targeting diagnostic labs, hospitals, and healthcare providers. - Potential for recurring revenue streams through AI-powered diagnostic subscriptions and consumables. - Regulatory & Clinical Traction for a Competitive Edge. Ongoing clinical validation and regulatory alignment with CLIA/CAP-accredited labs. RF-based diagnostics provide a faster, non-invasive alternative to traditional molecular testing. - With high asset valuation, driven by significant equipment costs, the company stands out in the diagnostics sector with its advanced technological infrastructure. - With a compact team of 6 skilled employees, the business emphasizes agility and innovation in its operations, facilitating quick progress in the fast-paced diagnostic technology sector.

Strong foundation: Backed by a well-established parent company with years of experience in recruitment and talent sourcing. - Growing client base: Serving 20+ clients across industries like tech, healthcare, and finance, with rapid adoption signalling strong market fit. - Revenue model: Flexible subscription plans with both monthly and yearly options, pay-per-use options, and enterprise licensing to cater to diverse client needs. - Experienced founders: Led by professionals with 18+ years of expertise in recruitment, HR tech, and AI, driving growth and innovation. - Strategic partnerships: Collaborations with tech providers, recruitment agencies, and HR tools for seamless integration and market expansion. - Industry recognition: Named among top recruitment startups and recognized for AI-driven innovation. - Scalable growth: Focused on expanding internationally, enhancing features like diversity hiring tools, and supporting high-volume recruitment. - There are 10 permanent employees, with additional interns and freelancers.